What they were paid
Apellis Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $77,500 | $199,992 | $199,973 | — | $477,465 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Apellis Pharmaceuticals, Inc. DEF 14A filed April 23, 2025, accession 0000950170-25-056966, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Apellis Pharmaceuticals pays directors a $50,000 cash retainer and $400,000 in Options and RSUs.
Committees
FY2024 · as the proxy prints themAudit · Nominating/Governance
The rest of the Apellis Pharmaceuticals board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Alec Machiels | Independent Director | $492,465 |
| Cedric Francois | Director | $0 |
| Craig Wheeler | Independent Director | — |
| Gerald Chan | Independent Director | $498,715 |
| Keli Walbert | Independent Director | — |
| Paul Fonteyne | Independent Director | $487,465 |
| Stephanie Monaghan O'Brien | Director | $484,965 |
The full Apellis Pharmaceuticals compensation record
free company briefThis page is one director within Apellis Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat